Results 231 to 240 of about 51,241 (251)

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

Lancet, The, 2012
David Laharie, Matthieu Allez, Maria Nachury   +2 more
exaly  

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

Lancet, The, 2019
Craig S Anderson, Richard I Lindley, Xiaoying Chen   +2 more
exaly  

Intravenous thrombolysis

1994
openaire   +1 more source

Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial

Lancet, The, 2012
Claire M Rickard, Nicole Marsh, Matthew McGrail   +2 more
exaly  

Intravenous Thrombolysis

Anas Alrohimi, Ashfaq Shuaib, Rajsrinivas Parthasarathy, Mahesh Pundlik Kate   +3 more
openaire   +1 more source

Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial

Lancet, The, 2018
Claire M Rickard, Nicole Marsh, Joan Webster   +2 more
exaly  

Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial

Lancet, The, 2012
Fang Gao Smith, Gavin D Perkins, Frcp, Fficm, Simon Gates   +2 more
exaly  

Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial

Lancet, The, 2012
Holger Thiele, Jochen Wöhrle, Ingo Eitel   +2 more
exaly  

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial

Lancet, The, 2015
David Veillard
exaly  

Intravenous thrombolysis of basilar artery thrombosis

Annals of Neurology, 2014
openaire   +2 more sources